project id: TCGA-COAD; case submitter id: TCGA-QG-A5Z2; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 61; days to birth: -22367; ethnicity: not hispanic or latino; gender: male; race: black or african american; vital status: Alive; year of birth: 1951; age at diagnosis: 22367; ajcc pathologic m: M0; ajcc pathologic n: N0; ajcc pathologic stage: Stage I; ajcc pathologic t: T2; ajcc staging system edition: 7th; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 952.0; icd 10 code: C18.0; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cecum; synchronous malignancy: No; tissue or organ of origin: Cecum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: no; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 337; days to sample procurement: 0; initial weight: 140.0; portion submitter id: TCGA-QG-A5Z2-01A-11; percent lymphocyte infiltration: 15.0; percent monocyte infiltration: 1.0; percent necrosis: 0.0; percent neutrophil infiltration: 1.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0;